Altamira Therapeutics Ltd. (CYTOF) vs Atrinsic Inc. (PTIX)

Altamira Therapeutics Ltd. and Atrinsic Inc. are both Biotechnology companies. Atrinsic Inc. is the larger, with a market value of $1.3M against $1.1M — 1.1× the size. Altamira Therapeutics Ltd. has negative trailing earnings, so its P/E is not meaningful; Atrinsic Inc. trades at 0.3×. Across the 10 metrics below, Atrinsic Inc. leads on 6 and Altamira Therapeutics Ltd. on 4.

Valuation

Metric CYTOF PTIX Biotechnology median
P/E n/m 0.35 7.88
P/S n/m n/m 11.47
P/B 0.07 0.82 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m n/m 10.73
Earnings yield (57,271.43%) 285.90% (28.84%)
Free cash flow yield (8,408.06%) (152.63%) (23.03%)

Profitability

Metric CYTOF PTIX Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (338.24%) (57.72%)
Return on assets 0.00% 390.69% (49.22%)
Return on invested capital 0.00% (229.86%) 0.00%

Growth

Metric CYTOF PTIX Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) 65.95% 188.24% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CYTOF PTIX Biotechnology median
Debt to equity 0.11 0.00 0.00
Current ratio 0.11 0.66 4.73
Net debt to EBITDA 0.15 0.52 0.96

Dividend

Metric CYTOF PTIX Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric CYTOF PTIX Biotechnology median
Market cap 1.13m 1.27m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack